1. Advances in aromatase inhibition. Clinical efficacy and tolerability in the treatment of breast cancer;Buzdar;Clin. Cancer Res.,2001
2. B. Thurlimann, J.R.F. Robertson, J. Bonneterre, Efficacy of tamoxifen following Arimidex (anastrozole) as first-line treatment for advanced breast cancer (ABC) in postmenopausal (PM) women (abstract 162), Proceedings of the 23rd Annual San Antonio Breast Cancer Symposium, Breast Cancer Res. Treat. 64 (2000) 51.
3. Anastrozole shows evidence of activity in postmenopausal patients who have responded or stabilized on formestane therapy;Harper-Wynne;Eur. J. Cancer,1999
4. R. Vidya, J.M. Dixon, D.B. Evans, W.R. Miller, Paradoxical effects of aromatase inhibitors: increased activity of target enzyme following prior exposure to some but not all aromatase inhibitors (abstract 274), Proceedings of the 23rd Annual San Antonio Breast Cancer Symposium, Breast Cancer Res. Treat. 64 (2000) 74.
5. British Breast Group. Assessment of response to treatment in advanced breast cancer, Lancet 2 (1974) 38–39.